Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry
- 1 December 2012
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 12 (6), 423-432
- https://doi.org/10.1016/j.clml.2012.06.008
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)Blood, 2011
- Improvement in Survival of Older Adults with Multiple Myeloma: Results of an Updated Period Analysis of SEER DataThe Oncologist, 2011
- Multiple MyelomaThe New England Journal of Medicine, 2011
- Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patientsBlood, 2011
- Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the ClinicMayo Clinic Proceedings, 2010
- Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010Haematologica, 2009
- Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working GroupBlood, 2008
- Improved survival in multiple myeloma and the impact of novel therapiesBlood, 2008
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- Multiple myeloma in the geriatric patientCancer, 1990